Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose naloxone infusion for pain and hyperalgesia after inguinal herniotomy
2013-004709-17Phase 2Terminated
- Sponsor
- Rigshospitalet
- Start
- Feb 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Persistent postsurgical pain (PPSP), hyperalgesia and allodynia comparing High-dose naloxone infusion with Placebo infusion (2 arms). Primary endpoint: Secondary hyperalgesia area at injury site. Started Feb 2014; status: terminated.
02
Drugs
naloxone
03
Conditions
Persistent postsurgical pain (PPSP)hyperalgesiaallodynia
Beyond the preview
Go deeper on 2013-004709-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004709-17.